Free Trial

Atb Cap Markets Forecasts Reduced Earnings for Canopy Growth

Canopy Growth logo with Medical background

Canopy Growth Co. (NASDAQ:CGC - Free Report) - Investment analysts at Atb Cap Markets lowered their FY2025 earnings estimates for shares of Canopy Growth in a research note issued on Sunday, February 9th. Atb Cap Markets analyst F. Gomes now forecasts that the company will earn ($2.27) per share for the year, down from their previous estimate of ($2.18). Atb Cap Markets currently has a "Strong Sell" rating on the stock. The consensus estimate for Canopy Growth's current full-year earnings is ($2.38) per share. Atb Cap Markets also issued estimates for Canopy Growth's Q4 2025 earnings at ($0.27) EPS, FY2026 earnings at ($0.73) EPS, FY2027 earnings at ($0.20) EPS, FY2028 earnings at ($0.15) EPS and FY2029 earnings at ($0.08) EPS.

Canopy Growth Price Performance

Shares of NASDAQ CGC remained flat at $1.89 during trading hours on Wednesday. 5,882,043 shares of the company traded hands, compared to its average volume of 7,716,115. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.07 and a current ratio of 1.39. The firm has a market capitalization of $246.51 million, a P/E ratio of -0.38 and a beta of 0.86. The firm's 50 day simple moving average is $2.52 and its two-hundred day simple moving average is $4.05. Canopy Growth has a 1 year low of $1.75 and a 1 year high of $14.92.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of CGC. Vontobel Holding Ltd. purchased a new stake in Canopy Growth during the third quarter worth $92,000. Stratos Wealth Advisors LLC purchased a new stake in Canopy Growth during the third quarter worth $97,000. Lake Street Private Wealth LLC boosted its holdings in Canopy Growth by 47.6% during the third quarter. Lake Street Private Wealth LLC now owns 44,638 shares of the company's stock worth $215,000 after buying an additional 14,398 shares in the last quarter. PFG Investments LLC purchased a new stake in Canopy Growth during the third quarter worth $54,000. Finally, Financial Advocates Investment Management purchased a new stake in Canopy Growth during the third quarter worth $57,000. Institutional investors and hedge funds own 3.33% of the company's stock.

About Canopy Growth

(Get Free Report)

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz & Bickel segments.

See Also

Earnings History and Estimates for Canopy Growth (NASDAQ:CGC)

Should You Invest $1,000 in Canopy Growth Right Now?

Before you consider Canopy Growth, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Canopy Growth wasn't on the list.

While Canopy Growth currently has a "Sell" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Will it Spark a Rally or Trigger a Sell-Off?
Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock
The EXACT Date of Next Stock Market Crash

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines